Assay ID | Title | Year | Journal | Article |
AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1322458 | Inhibition of mouse NGF binding to p75 (unknown origin) by SPR method relative to control | 2017 | Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
| Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain. |
AID182690 | Inhibition of passive cutaneous anaphylaxis (PCA) reaction in rats by intraperitoneal administration of 5 mg/kg | 1981 | Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
| Pyrazolo[5,1-b]quinazolin-9-ones: a new series of antiallergic agents. |
AID1322460 | Inhibition of mouse NGF binding to TrkA (unknown origin) by SPR method relative to control | 2017 | Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
| Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain. |
AID1322457 | Inhibition of mouse NGF binding to p75 (unknown origin) by SPR method | 2017 | Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
| Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain. |
AID182824 | Inhibition of passive cutaneous anaphylaxis (PCA) reaction in rats, peroral administration 5 mg/kg | 1981 | Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
| Pyrazolo[5,1-b]quinazolin-9-ones: a new series of antiallergic agents. |
AID1322459 | Inhibition of mouse NGF binding to TrkA (unknown origin) by SPR method | 2017 | Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
| Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain. |
AID147189 | Inhibition of [125I]- NGF binding to extracellular domain of p75 receptor | 1995 | Journal of medicinal chemistry, Oct-27, Volume: 38, Issue:22
| Kynurenic acid derivatives inhibit the binding of nerve growth factor (NGF) to the low-affinity p75 NGF receptor. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |